Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Charlton

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 19, 2005
Retransplantation for HCV--the view through a broken crystal ballMichael Charlton
The American Journal of Gastroenterology|February 22, 2007
Noninvasive indices of fibrosis in NAFLD: starting to think about a three-hit (at least) phenomenonMichael Charlton
Gastroenterology & Hepatology|June 27, 2018
Risk of Hepatocellular Carcinoma in Patients With Nonalcoholic SteatohepatitisMichael Charlton
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2006
Perioperative viral kinetics: new insights or the Emperor's new clothes?Michael Charlton
Hepatology (Baltimore, Md.)|April 9, 2008
Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?Michael Charlton
Current Opinion in Organ Transplantation|May 9, 2013
Evolving aspects of liver transplantation for nonalcoholic steatohepatitisMichael Charlton
Lancet (London, England)|March 10, 2018
FGF-19 agonism for NASH: a short study of a long diseaseMichael Charlton
Hepatology (Baltimore, Md.)|June 29, 2011
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktailMichael Charlton
Gastroenterology & Hepatology|April 7, 2025
Insights Into Combination Therapy for Metabolic Dysfunction-Associated SteatohepatitisMichael Charlton
Gastroenterology & Hepatology|May 26, 2021
The Future of Treatment for Nonalcoholic SteatohepatitisMichael Charlton
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 19, 2005
Retransplantation for HCV--the view through a broken crystal ballMichael Charlton
The American Journal of Gastroenterology|February 22, 2007
Noninvasive indices of fibrosis in NAFLD: starting to think about a three-hit (at least) phenomenonMichael Charlton
Gastroenterology & Hepatology|June 27, 2018
Risk of Hepatocellular Carcinoma in Patients With Nonalcoholic SteatohepatitisMichael Charlton
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2006
Perioperative viral kinetics: new insights or the Emperor's new clothes?Michael Charlton
Hepatology (Baltimore, Md.)|April 9, 2008
Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?Michael Charlton
Current Opinion in Organ Transplantation|May 9, 2013
Evolving aspects of liver transplantation for nonalcoholic steatohepatitisMichael Charlton
Lancet (London, England)|March 10, 2018
FGF-19 agonism for NASH: a short study of a long diseaseMichael Charlton
Hepatology (Baltimore, Md.)|June 29, 2011
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktailMichael Charlton
Gastroenterology & Hepatology|April 7, 2025
Insights Into Combination Therapy for Metabolic Dysfunction-Associated SteatohepatitisMichael Charlton
Gastroenterology & Hepatology|May 26, 2021
The Future of Treatment for Nonalcoholic SteatohepatitisMichael Charlton
Pageof 14